Need Help? Call 1­-866-­796-­7386
« back to stock screener

  REGN stock: Regeneron Pharmaceuticals Inc

Current Rating
Strong Sell

Previous Rating:

Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$373.00
Market Cap
40.21B
Sector
Health Care
Div. Growth
-
P/E
48.7
P/B
8.88
P/S
8.13
Dividend %
-
P/CF
-
P/FCF
45.4
Op. Cash Flow
1.47M
FCF
8.2
Op. Margin
27.40%
Net Margin
18.40%
ROE
21.30%
ROI
18.20%
ROA
13.80%
EPS Growth
38.60%
Current Ratio
2.6
Debt/Equity
7.90%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Fibrocell Science Inc (FCSC) $2.00 - - 31.3M Strong Buy
ProPhase Labs Inc (PRPH) $1.99 - - 34.7M Strong Buy
Eleven Biotherapeutics Inc (EBIO) $2.01 - - 47.5M Strong Buy
Zynex Inc. (ZYXI) $0.31 - - 10.3M Strong Buy
American Renal Associates Hold (ARA) $16.86 - - 706.6M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More